Chromosome 3: Functions, Genes, and Related Disorders

Chromosome 3 is the sixth-largest human chromosome, carrying roughly 1,100 protein-coding genes spread across about 200 million base pairs. Those genes influence an unusually wide range of bodily functions, from how your heart beats to whether certain cancers take hold to how your immune system handles HIV. The chromosome’s short arm (3p) is especially dense with tumor suppressor genes whose loss drives kidney, lung, and other cancers, while its long arm (3q) harbors genes critical for eye development, stem cell identity, and cell signaling. Understanding what chromosome 3 does means walking through some of the most consequential genes in human medicine.

A Cluster of Tumor Suppressors on the Short Arm

The short arm of chromosome 3, particularly the region called 3p, is sometimes described as a hotspot for cancer biology. Four tumor suppressor genes sit close together here, and losing even one of them can set the stage for uncontrolled cell growth. The most studied is VHL, the gene behind von Hippel-Lindau disease. The VHL protein normally acts as a kind of oxygen sensor: when oxygen levels are adequate, it tags a growth-promoting protein called HIF for destruction. When VHL is missing or broken, HIF accumulates and drives cells to grow and form new blood vessels as if oxygen were scarce, fueling tumor development.¹ People who inherit a faulty copy of VHL are at elevated risk for clear cell renal cell carcinoma (the most common form of kidney cancer), as well as tumors of the central nervous system called hemangioblastomas and tumors of the adrenal glands called paragangliomas.²

Sitting nearby on 3p are three additional genes that help regulate how DNA is packaged and read: PBRM1, BAP1, and SETD2. These chromatin-remodeling genes protect genomic stability and maintain the normal patterns of gene expression that keep cells from becoming cancerous. In clear cell renal cell carcinoma, it is common for VHL to be lost alongside one or more of these three neighbors, because large-scale deletions of the 3p region can wipe out multiple genes at once.³ The combined loss of VHL and these chromatin regulators appears critical for tumor progression, not just initiation.⁴ BAP1 mutations also play a role in uveal melanoma, a cancer of the eye, where partial losses of chromosome 3 in the BAP1 region are a recognized prognostic marker.

The Fragile Site That Breaks in Cancer

A different part of 3p, at band 3p14.2, contains one of the most breakage-prone spots in the entire human genome: a common fragile site called FRA3B. Fragile sites are stretches of DNA that are especially vulnerable to breaking when cells are under replication stress. FRA3B sits within a gene called FHIT (fragile histidine triad), and the breakage that occurs here is not just a curiosity; it has direct consequences for cancer. The FHIT protein functions as a tumor suppressor, and it is partially or entirely lost in most human cancers.⁵

What makes FHIT unusual among tumor suppressors is that losing just one working copy appears sufficient to compromise its protective function, rather than needing both copies knocked out as the classic model of tumor suppression would predict.⁵ Sequencing of the FRA3B region revealed that the locus is riddled with repetitive DNA elements that make it a frequent target for recombination events, leading to internal deletions of the FHIT gene in cancer cells.⁶ Aberrant FHIT transcripts have been found in roughly half of esophageal, stomach, and colon carcinomas studied, as well as in kidney cancers associated with a translocation breakpoint at 3p14.2.⁷

Oncogenes on the Long Arm

While the short arm is loaded with genes that normally prevent cancer, the long arm of chromosome 3 carries genes that, when amplified or overactivated, push cells toward malignancy. The region 3q26 is frequently amplified in squamous cell cancers of the head, neck, and lungs. Two genes at this locus get the most attention: PIK3CA, which encodes a subunit of a key signaling enzyme involved in cell growth, and SOX2, a transcription factor important in stem cell biology.

In a study of laryngeal dysplasias, PIK3CA amplification was detected in about half of cases and SOX2 amplification in roughly a third; both were significantly associated with the risk of progressing to laryngeal cancer.⁸ In lung squamous cell carcinoma, amplification of PIK3CA and another gene at 3q called YEATS2 has been linked to more aggressive tumor behavior.⁹ PIK3CA is also a therapeutic target: drugs that inhibit the PI3K pathway are already used in certain breast cancers and are under investigation for squamous cell tumors driven by 3q amplification.

Heart Rhythm and the SCN5A Gene

Not everything on chromosome 3 relates to cancer. The SCN5A gene, located at 3p22.2, encodes the main sodium channel protein in cardiac muscle cells. Sodium channels are what generate the electrical impulse that triggers each heartbeat, so mutations here can have dramatic consequences for heart rhythm. The direction of the defect matters: mutations that cause the channel to let in too much sodium produce long QT syndrome, a condition where the heart takes too long to recharge between beats and is prone to dangerous arrhythmias. Mutations that reduce sodium flow cause Brugada syndrome, a different arrhythmia disorder that can lead to sudden cardiac arrest.¹⁰

Specific missense mutations in SCN5A have been characterized in affected individuals, including mutations in the channel’s cytoplasmic linker and C-terminal domain that alter how the channel opens and closes.¹¹ Some SCN5A mutations also cause dilated cardiomyopathy, in which the heart muscle weakens and stretches over time. The range of heart conditions traced to this single gene illustrates how one channel protein, when even slightly altered, can ripple across multiple aspects of cardiac function.

CCR5 and HIV Resistance

One of the more remarkable stories in chromosome 3 genetics involves CCR5, a gene at 3p21.31 that encodes a receptor on the surface of immune cells. HIV uses this receptor as a doorway to enter and infect cells. A naturally occurring mutation, a 32-base-pair deletion called CCR5-Δ32, produces a shortened, nonfunctional version of the receptor. People who carry two copies of this deletion are nearly completely resistant to HIV infection, regardless of their level of exposure.¹²

Carrying just one copy offers a more modest degree of protection. A meta-analysis found that people heterozygous for the deletion had a small but statistically significant increase in infection risk compared to those with two normal copies among the general population, but among people with known exposure to HIV, carrying even one copy of the deletion significantly reduced infection risk.¹³ The CCR5-Δ32 variant is most common in people of northern European descent, found in roughly 10% of that population. This discovery has had clinical consequences: the drug maraviroc blocks the CCR5 receptor to prevent HIV entry, and two patients have been functionally cured of HIV after receiving bone marrow transplants from donors homozygous for the deletion.

SOX2 and Eye Development

SOX2, the same gene whose amplification drives certain cancers when overexpressed, plays an entirely different role during embryonic development. Located at 3q26.33, SOX2 encodes a transcription factor essential for the formation of the eyes, brain, and other structures. When one copy of SOX2 is lost or mutated before birth, the result can be severe: anophthalmia (absence of one or both eyes) or microphthalmia (abnormally small eyes). SOX2 haploinsufficiency is one of the most common genetic causes of these devastating developmental eye malformations.¹⁴

The condition can also include brain abnormalities, esophageal atresia, and genital anomalies, a constellation sometimes called syndromic microphthalmia-3.¹⁵ Some cases arise from point mutations in SOX2 itself, while others result from chromosomal deletions large enough to remove SOX2 along with surrounding genes. One case report documented a 3.5 megabase deletion at 3q26 that included SOX2 and caused microphthalmia, coloboma (a gap in eye structures), and anal atresia, a feature not previously linked to SOX2 loss.¹⁶ The variability in symptoms among people with SOX2 mutations likely reflects background genetic differences that modify how severely the loss of one copy affects development.

Rhodopsin and Inherited Blindness

Another vision-related gene on chromosome 3 is RHO, located at 3q22.1, which encodes rhodopsin, the light-sensitive pigment in the rod cells of the retina. Mutations in rhodopsin are the most common cause of autosomal dominant retinitis pigmentosa, a progressive condition in which rod cells degenerate over years, leading to tunnel vision and eventually severe visual impairment. Over 150 different mutations have been identified in the RHO gene, and they cause disease through a variety of mechanisms, from misfolding of the rhodopsin protein to its inability to properly respond to light.¹⁷ Some rhodopsin mutations instead cause congenital stationary night blindness, a non-progressive condition in which night vision is poor but daytime vision is largely preserved. The specific mutation determines whether the disease progresses or remains stable.

Skin Fragility and Type VII Collagen

Chromosome 3 also hosts COL7A1 at 3p21.31, the gene encoding type VII collagen. This protein forms the anchoring fibrils that attach the outer layer of skin to the tissue beneath. When COL7A1 is mutated, those anchoring fibrils are reduced, malformed, or absent, causing dystrophic epidermolysis bullosa, a condition where the skin blisters and tears with minimal friction or trauma. Dozens of distinct mutations in COL7A1 have been identified, ranging from dominant forms that cause relatively mild blistering to recessive forms with severe, lifelong skin fragility, chronic wounds, and increased risk of aggressive skin cancers later in life.¹⁸ A large study of 152 extended families confirmed the spectrum of COL7A1 mutations and highlighted how consanguinity in certain populations increases the frequency of recessive forms.¹⁹

When Pieces of Chromosome 3 Go Missing

Beyond single-gene disorders, larger structural changes to chromosome 3 produce their own recognizable syndromes. Deletions at the far end of the short arm, known as 3p deletion syndrome, cause a characteristic pattern of growth delay, intellectual disability, low muscle tone, and distinctive facial features including a wide nasal bridge, drooping eyelids, and small jaw. Among reported cases, growth retardation appears in about 95%, intellectual disability in about 79%, and congenital heart defects in about 43%.²⁰ Researchers have been working to narrow down the critical regions responsible for specific features, such as a candidate region for the heart defects.²¹

At the other end of the chromosome, a 1.6-megabase deletion at 3q29 is one of the strongest known genetic risk factors for schizophrenia, increasing the risk at least 20-fold. This deletion, which usually arises spontaneously rather than being inherited, also carries elevated risk for autism spectrum disorder and intellectual disability.²² The deletion is rare, found in roughly 1 in 30,000 people, but its outsized psychiatric impact makes it important for understanding how chromosomal losses can disrupt brain development and function.

Metabolic Genes and Energy Regulation

Chromosome 3 also carries genes involved in metabolism. The HGD gene, at 3q13.33, encodes the enzyme homogentisate 1,2-dioxygenase. Mutations that knock out this enzyme cause alkaptonuria, a rare recessive condition in which a byproduct of protein metabolism called homogentisic acid accumulates in the body. Over decades, this acid deposits in cartilage and connective tissue, turning them dark and brittle, a process called ochronosis. Affected joints can degenerate severely. In a study of Jordanian families with a high degree of consanguinity, a single recurrent missense variant in HGD was identified across multiple unrelated families, pointing to a strong founder effect in that population.²³

Another metabolically relevant gene on chromosome 3 is PPARGC1A (also known as PGC-1α), located at 3p25.3. This gene encodes a master regulator of mitochondrial energy production. Variants in PPARGC1A have been associated with type 2 diabetes and cardiovascular disease. In a study of Puerto Rican adults in Boston, two independent variants in this gene were significantly associated with type 2 diabetes, with odds ratios of about 1.35 and 2.46 respectively.²⁴ The same variants were also linked to DNA damage and cardiovascular risk, suggesting the gene’s influence on mitochondrial function has broad downstream effects on aging-related diseases.

Chromosome 3 in Psychiatric Genetics

Beyond the 3q29 deletion’s link to schizophrenia, other regions of chromosome 3 have emerged in studies of mood disorders. A genome-wide linkage study of families with severe depression found a statistically significant signal at 3p25-26, with a peak LOD score of 4.0, meaning the evidence for a depression-related gene in that region was strong enough to meet genome-wide thresholds. However, follow-up association mapping in a separate sample did not replicate the finding, which is not unusual in psychiatric genetics where large effect sizes from linkage studies often break down into multiple smaller contributing variants that are harder to pin down individually.²⁵ The region of interest overlaps with PPARGC1A, raising questions about whether mitochondrial energy regulation in the brain might play a role in vulnerability to depression.

Parent-of-Origin Effects on Chromosome 3

Not all genetic effects are straightforward “inherit a variant, get a trait” stories. Some genes on chromosome 3 behave differently depending on whether they were inherited from your mother or your father, a phenomenon related to genomic imprinting. In a study of a large Hutterite pedigree, maternally inherited alleles at two positions on chromosome 3 were associated with reduced lung function as measured by forced expiratory volume. One of these variants sits near ROBO2, a gene expressed in the lung and brain, and the other near a small RNA gene whose expression is not yet well characterized.²⁶ Another chromosome 3 variant showed opposite effects on lung function depending on which parent it came from, and it sits near CNTN3, a gene that mouse studies suggest is imprinted and maternally expressed in the placenta. These findings are preliminary, but they hint that some of chromosome 3’s influence on health depends on inheritance patterns that standard genetic testing does not always capture.

An Evolutionary History Written in Rearrangements

Chromosome 3 has not always looked the way it does in humans. Comparing chromosome maps across primate species reveals that human chromosome 3 arrived at its current form through at least two overlapping inversions, large-scale flips of DNA segments, from the ancestral arrangement found in the common ancestor of Old World primates. This reconstruction, based on molecular mapping rather than older banding techniques, overturned the simpler scenario previously accepted by geneticists, which proposed that only one inversion was needed.²⁷ The Bornean orangutan’s version of this chromosome also differs from the ancestor’s, through a different set of rearrangements, meaning neither humans nor orangutans preserved the original chromosome form.

Mapping of over 100 region-specific DNA clones from human chromosome 3 across orangutans, gibbons, and Old and New World monkeys identified at least 14 different evolutionary breakpoints scattered along the chromosome’s length, though certain regions appear far more prone to rearrangement than others.²⁸ One region at 3q21.3 has been a particular hotspot for evolutionary breakage. Three independent breakpoints in different primate lineages were localized within a single 230-kilobase segment, and the same breakpoint zones overlap with breaks in chromosomal organization seen in mice, rats, and chickens, supporting the idea that certain stretches of DNA are inherently prone to rearrangement across vertebrate evolution rather than breaking at random.²⁹ The same fragility that shaped our chromosome over millions of years may also contribute to the cancer-associated breakage that chromosome 3 is known for today.